This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vahl, N. Articles by Jørgensen, J. O. L. Search for Related Content PubMed PubMed Citation Articles by Vahl, N. Articles by Jørgensen, J. O. L.

Metabolic Effects and Pharmacokinetics of a Growth Hormone Pulse in Healthy Adults: Relation to Age, Sex, and Body Composition

Medical Department M (Endocrinology and Diabetes) and Center for Clinical Pharmacology, Aarhus University Hospital, Kommunehospitalet, Aarhus, Denmark

Address all correspondence and requests for reprints to: Nina Vahl, M.D., Medical Department M, Aarhus Kommunehospital, DK-8000 C Aarhus, Denmark.

The acute effects of a single GH pulse have previously been studied in young males. It is, however, likely that both the metabolic effects and the pharmacokinetics of GH may differ between age groups and sexes. We studied 36 healthy, clinically nonobese adults of both sexes, who were divided into a young group (mean age, 29.6 yr) and an older group (mean age, 51.0 yr). On 2 separate occasions, they received an iv bolus of either GH (200 µg) or saline followed by blood sampling for 5 h. Glucose turnover was estimated by infusion of [3-³H]glucose, and indirect calorimetry was performed before and 2 h after the bolus infusions. Body composition (computed tomography scan and dual energy x-ray absorptiometry) was performed at baseline. Baseline levels of serum insulin-like growth factor I (IGF-I) was lower in older subjects, whereas circulating IGF-binding protein-1 and lipid intermediates were lower in males than in females. The area under the GH curve was lower in older subjects (young, 3978 ± 1532 µg/L·24 h; older, 1144 ± 79; P = 0.001), whereas the elimination half-life did not differ with age (young, 18.1 ± 0.9 min; older, 16.4 ± 0.8; P = NS). The MCR and apparent distribution volume of GH were higher in older subjects [MCR: young, 0.11 ± 0.02 min/L; older, 0.19 ± 0.01; P = 0.001; apparent distribution volume: young, 2.5 ± 0.4 L; older, 4.5 ± 0.3; P < 0.001). Both MCR and V_d correlated inversely with age and positively with indexes of adiposity. GH significantly increased lipid intermediates, but the response was higher in young subjects and males. By contrast, the ability of GH to acutely suppress IGF-binding protein-1 was more pronounced in older subjects and females. Serum levels of insulin and IGF-I did not differ significantly between GH and saline treatment groups. GH decreased the respiratory exchange ratio and increased resting energy expenditure, with no age or gender differences. A gradual decline over time in plasma levels and rate of turnover of glucose was recorded after both GH and saline. The following conclusions were reached. 1) The MCR and V_d of GH increase with age and correlate positively with fat mass. 2) Older subjects are responsive to the acute lipolytic effects of GH, but the response is higher in young subjects and in males. 3) Adipose tissue may be actively involved in the distribution and clearance of GH. 4) Age, sex, and body composition interact with GH in a complex manner, involving clearance, distribution, and metabolic actions of the hormone.

This article has been cited by other articles:

				P. Y. Takahashi, P. Votruba, M. Abu-Rub, K. Mielke, and J. D. Veldhuis Age Attenuates Testosterone Secretion Driven by Amplitude-Varying Pulses of Recombinant Human Luteinizing Hormone during Acute Gonadotrope Inhibition in Healthy Men J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3626 - 3632. [Abstract] [Full Text] [PDF]

				A. Keller, Z. Wu, J. Kratzsch, E. Keller, W. F Blum, A. Kniess, R. Preiss, J. Teichert, C. J Strasburger, and M. Bidlingmaier Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration Eur. J. Endocrinol., June 1, 2007; 156(6): 647 - 653. [Abstract] [Full Text] [PDF]

				J. W. Lu, J. P. McMurtry, and C. N. Coon Developmental Changes of Plasma Insulin, Glucagon, Insulin-like Growth Factors, Thyroid Hormones, and Glucose Concentrations in Chick Embryos and Hatched Chicks Poult. Sci., April 1, 2007; 86(4): 673 - 683. [Abstract] [Full Text] [PDF]

				M. van Dijk, P. Mulder, M. Houdijk, J. Mulder, K. Noordam, R. J. Odink, C. Rongen-Westerlaken, P. Voorhoeve, J. Waelkens, J. Stokvis-Brantsma, et al. High Serum Levels of Growth Hormone (GH) and Insulin-Like Growth Factor-I (IGF-I) during High-Dose GH Treatment in Short Children Born Small for Gestational Age J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1390 - 1396. [Abstract] [Full Text] [PDF]

				K. Stokes, M. Nevill, J. Frystyk, H. Lakomy, and G. Hall Human growth hormone responses to repeated bouts of sprint exercise with different recovery periods between bouts J Appl Physiol, October 1, 2005; 99(4): 1254 - 1261. [Abstract] [Full Text] [PDF]

				C. Soares-Welch, L. Farhy, K. L. Mielke, F. H. Mahmud, J. M. Miles, C. Y. Bowers, and J. D. Veldhuis Complementary Secretagogue Pairs Unmask Prominent Gender-Related Contrasts in Mechanisms of Growth Hormone Pulse Renewal in Young Adults J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2225 - 2232. [Abstract] [Full Text] [PDF]

				H. K. Gleeson, C. A. Lissett, and S. M. Shalet Insulin-Like Growth Factor-I Response to a Single Bolus of Growth Hormone Is Increased in Obesity J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1061 - 1067. [Abstract] [Full Text] [PDF]

				T. K. Hansen, C. H. Gravholt, H. Orskov, M. H. Rasmussen, J. S. Christiansen, and J. O. L. Jorgensen Dose Dependency of the Pharmacokinetics and Acute Lipolytic Actions of Growth Hormone J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4691 - 4698. [Abstract] [Full Text] [PDF]

				T. K. Hansen, J. O. L. Jorgensen, and J. S. Christiansen Body Composition and Circulating Levels of Insulin, Insulin-Like Growth Factor-Binding Protein-1 and Growth Hormone (GH)-Binding Protein Affect the Pharmacokinetics of GH in Adults Independently of Age J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2185 - 2193. [Abstract] [Full Text] [PDF]

				P. F. Catalina, M. A. Andrade, R. V. Garcia-Mayor, and F. Mallo Altered GH Elimination Kinetics in Type 1 Diabetes Mellitus Can Explain the Elevation in Circulating Levels: Bicompartmental Approach J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1785 - 1790. [Abstract] [Full Text] [PDF]

				R. I. G. Holt, E. Webb, C. Pentecost, and P. H. Sonksen Aging and Physical Fitness Are More Important Than Obesity in Determining Exercise-Induced Generation of GH J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5715 - 5720. [Abstract] [Full Text] [PDF]

				R. Dall, S. Longobardi, C. Ehrnborg, N. Keay, T. Rosén, J. O. L. Jørgensen, R. C. Cuneo, M. A. Boroujerdi, A. Cittadini, R. Napoli, et al. The Effect of Four Weeks of Supraphysiological Growth Hormone Administration on the Insulin-Like Growth Factor Axis in Women and Men J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4193 - 4200. [Abstract] [Full Text]

				M. C. Kammerl, D. Grimm, C. Nabel, F. Schweda, M. Bach, S. Fredersdorf, H. Piehler, S. R. Holmer, G. A. J. Riegger, E. P. Kromer, et al. Effects of growth hormone on renal renin gene expression in normal rats and rats with myocardial infarction Nephrol. Dial. Transplant., June 1, 2000; 15(6): 786 - 790. [Abstract] [Full Text] [PDF]

				C. H. Gravholt, O. Schmitz, L. Simonsen, J. Bulow, J. S. Christiansen, and N. Moller Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E848 - E854. [Abstract] [Full Text] [PDF]